China Clears World’s First Hepatitis E Vaccine, Locally Developed
This article was originally published in PharmAsia News
Executive Summary
China has cleared the world’s first vaccine for hepatitis E, developed by a team of academic researchers after 14 years of government-funded work.
China has cleared the world’s first vaccine for hepatitis E, developed by a team of academic researchers after 14 years of government-funded work. The vaccine is intended for people at high risk for the disease, which is said by the World Health Organization to infect a third of the world population, primarily in Asia. China’s State FDA gave production approval last month, and the Ministry of Science and Technology said it would work with international groups to make the vaccine available in other countries. Chinese authorities consider the E type as the most common hepatitis among infected adults. (Click here for more
)
“China Approves Hepatitis E Vaccine” – Xinhua (China) (1/11/12)